# A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function

> **NCT02005744** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 26 (actual)

## Conditions studied

- Liver Dysfunction

## Interventions

- **DRUG:** CKD-501

## Key facts

- **NCT ID:** NCT02005744
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005744, "A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02005744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*